疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

# S8 Z# q8 q) a9 h% HApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
" y- o4 [4 t& F2 S* h! }3 O3 The vaccine industry 33
; c' L: V: y* J3 S  c7 _) D6 v* [4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
0 e& t; b1 Y' I5 e  X& d5 C, K% {. ulicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
6 s: i' w' S" ]  q5 F. }- V! B' l9 Adenovirus vaccines 113
1 G$ i2 m5 ]# l9 f! Q/ C10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
4 J; t! s: e; {- c13 Haemophilus influenzae vaccines 167
1 K' B/ k, C9 Z6 q! j14 Hepatitis A vaccines 183
/ d$ ~6 P7 W' }/ J# [5 u( x: ]15 Hepatitis B vaccines 205
+ o6 e) I$ f' R; U( r3 |16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
! X: R0 v6 i/ r7 P  U4 `1 U20 Measles vaccines 352
0 p1 d* ]" d  z+ X$ I21 Meningococcal vaccines 388
! o$ ^; g3 A" \  u' e22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
1 l' P4 C  v6 P4 m+ g6 w& w25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
2 }/ N" r+ P! s4 J8 \  W$ S28 Poliovirus vaccine-live 598
' B# }0 z, [$ @$ X! r29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
6 L$ T) b' M: R2 t6 c35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
" F) z/ J& b2 G# i9 ^7 j( Y5 E37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
9 O; H( K. E4 r2 g  K40 Combination vaccines 981
. j' [- m, b8 H) a/ o* P5 WSECTION 3: Vaccines in development and new vaccine strategies
0 K" s4 j7 {8 J8 _7 \# n4 R41 Biodefense and special pathogen vaccines 1008
4 Y, ~3 R  \* S42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
. O( l2 _! b* J5 Q7 C44 Dengue vaccines 1042
- Q0 v8 P3 d: W8 z# z45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
; ~; K' {3 y2 r, q50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
* a) J( q  \: v8 f( ]% U52 Lyme disease vaccines 1122
3 F" i4 p1 e% ^( s! S$ p; }53 Malaria vaccines 1133
' p' s9 M* W+ Z' m54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
* j1 i# J" W* Q7 _2 m56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
0 }; f" M6 \2 H* O+ a6 w59 Streptococcus group B vaccines 1176
1 T. ?' c# x8 t60 Technologies for making new vaccines 1182
6 H9 y! h: ]! u61 Alternative vaccine delivery methods 1200
$ O2 {/ q1 V( \2 p  _62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
* P4 w3 S4 }) ^$ L' A% @3 ~1 Q64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
- [& V% l& ?& F  b7 oSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
$ v+ E, ?9 R6 X: y! @/ l68 Immunization in Europe . 1334
" o: ?1 Z3 \: s* H3 H, `69 Immunization in the Asia-Pacific region 1353
- I5 r! ?( T$ ]70 Immunization in developing countries 1369
71 Community immunity 1395
4 e' U8 v: u6 h/ v4 A72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508


' Y: v! h/ A( u; q( p0 _
! W& s. s& i' W& j
" J* @1 }% Y# y6 ~

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

/ e9 j  [3 b2 v  b, t6 ^# h& f9 X3 @. uApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
' Q& ^6 n& `5 H# j
http://yun.baidu.com/share/link? ... 1&uk=3810996606
" F" ?* L& k, ~( U* h; i5 O, `+ d6 Y+ q
+ S% ~. ]& G. C6 [3 E0 ]SECTION 1: General aspects of vaccination
1 l3 b3 f" J8 l6 n) {; J: j# N1 A short history of vaccination 1
! z1 |; ]# \' c! k& B2 Vaccine immunology 14
9 F' b. ]; ]* |: _9 A; b3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
) A  W; _& @$ ~( |" n6 Vaccine additives and manufacturing residuals in the United States:
( ~* ^5 D# c* J8 X* f. ]4 n8 T7 @3 mlicensed vaccines 71
8 F) m% v0 @, V7 Passive immunization 80
0 w7 d/ C% B% r2 H) k: a2 p8 General immunization practices 88
SECTION 2: Licensed vaccines
; O3 X4 q/ y7 X! @9 E8 e( Z9 Adenovirus vaccines 113
6 n8 N& z9 V6 q4 f10 Anthrax vaccines 127
5 ~  c% y/ Y+ B# B4 _# ~11 Cholera vaccines 141
1 R8 A2 ^2 A+ R+ k+ D5 d7 W* O12 Diphtheria toxoid 153
' n! W! q  e% C% @$ B7 z  P2 S# V4 V13 Haemophilus influenzae vaccines 167
0 V. ^0 v; }1 b1 g2 Z/ `14 Hepatitis A vaccines 183
1 A6 W; d5 g0 R2 i15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
6 z/ _0 x4 V0 u; D19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
( ?) r, p+ a+ ~& p4 E; g24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
2 o2 Q9 o8 Z7 ]26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
/ {  q( Z* |% O1 k3 t* a9 m  H28 Poliovirus vaccine-live 598
% Y: t7 ?; \: t5 K7 ]2 T29 Rabies vaccines .646
* x$ N% m6 v# G! @$ I30 Rotavirus vaccines . 669
31 Rubella vaccine 688
" @$ C9 s6 o3 ?- f' D" `. e% K32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
3 F7 c2 {- Y6 q' F% P9 V: Z0 S34 Tick-borne encephalitis virus vaccines 773
6 p- m; V# F( g8 Q, O35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
( G+ Y0 l5 S& i% H2 K! T- g; Z37 Varicella vaccine 837
38 Yellow fever vaccine 870
. }/ ]- v8 N/ r9 \3 s39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
1 @6 O; w: u$ y7 t" y45 Diarrhea caused by bacteria 1052
2 I7 |9 x8 R% M' z$ H2 Y% h46 Ebola vaccine 1060
& K- o5 {0 t3 i9 n: Z6 y  M: g9 F47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
/ h  v- c! x$ F3 \  e* g8 U  `6 ]49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
' j% u0 K! Y: `6 i% [52 Lyme disease vaccines 1122
1 e# o$ C& X% ^4 K53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
; g+ Q- z4 Z" b* f- S7 ^* C56 Parasitic disease vaccines 1154
+ ~" D7 p8 L; p$ \57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
3 o/ v# a% F/ Z* u4 P59 Streptococcus group B vaccines 1176
) K8 @2 ?  A" y6 x* p* M/ A- ~60 Technologies for making new vaccines 1182
: X2 |: E8 R$ G5 J( _6 W) n61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
2 a+ P2 k5 v/ K- j6 DSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
" a6 \8 f+ b( |2 m( M2 l; l7 y- N64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
2 U7 o% J. ~2 u6 X( u2 D66 Vaccines for health care personnel 1290
! U: x6 \8 \& |4 E" \SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
& G' ?% Y' T! Q- @68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
- `% z, w! ^' ^70 Immunization in developing countries 1369
3 C2 ~; P) o% \6 |" C71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
0 }$ |" j% @/ n  s1 I. N. Q9 j73 Regulation and testing of vaccines 1427
; g) S. q9 _& p" h5 e; |8 l, o74 Regulation of vaccines in Europe 1447
/ V0 {( n& U! ]& M75 Regulation of vaccines in developing countries 1454
$ R( V8 \0 o/ W- ]0 {- |5 H* y5 h76 Vaccine safety 1464
77 Legal issues . 1481
# N8 j' U9 r: i: F78 Ethics 1508
! ^; {! e- j2 ~+ w( g, F/ N
) m6 A# ^4 p8 l* z  s

casarett

Vaccines, 6e, 2012
" c* W9 ~1 z+ H& o2 b
. M2 O; k% J4 qHardcover: 1570 pages
0 `- m% p! R2 J& u* sPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)
/ b, Y  e  |1 T  H
, w7 O# X$ `3 ^5 N8 V2013 BMA Medical Book Awards Highly Commended in Public Health!
0 `1 j( |2 ^: j$ tApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
- g$ [9 T9 t/ ?' q* Y" \& d8 k- |
: R$ `& N' |) q& B3 }, v( RGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
8 e9 e# w9 n, r3 X# Q3 J( GGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

( T- l& v& y9 S1 X% ZDownload link: http://pan.baidu.com/s/1i5NxwLR
5 H5 r5 A: E4 p' {) w8 L6 eCode for downloading: dv96